Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Industry Trends
  • Published:

Chiral-based therapeutics

Nature Biotechnology volume 15, pages 594–595 (1997)Cite this article

FDA mandates about the chiral forms of new or improved drugs are spurring interest-and sales.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lalonde, J., 1997. Practical catalysis with enzyme crystals. Chemtech 27: 38–45.

    CAS  Google Scholar 

  2. Davies, I.W. and Reider, P.J., 1996. Practical asymmetric synthesis. Chem. & Ind. 11: 412–415.

    Article  Google Scholar 

  3. Baum, R. 1993. C76 enantiomers resolved by osmylation technique. Chem. Eng. News 71: 35–36.

    Article  Google Scholar 

  4. Borman, S. 1994. Chemical-enzymatic technique used to make carbohydrates, glycopeptides. Chem. Eng. News 72: 37–39.

    Google Scholar 

  5. Persidis, A. 1997. Industry Trends: Carbohydrate-based therapeutics. Nature Biotechnology 15: 492–493.

    Article  Google Scholar 

  6. Persidis, A., 1995. Enabling technologies and the business of science. Bio/Technology 13: 1172–1176.

    CAS  Google Scholar 

  7. Pifferi G. and Perucca E. 1995. The cost benefit ratio of enantiomeric drugs. Eur. J. Drug Metab. Pharmacokinet. 20: 15–25.

    Article  CAS  Google Scholar 

  8. Burgess, K. 1996. Organometallic chemistry. Chem. & Ind. 24: 988.

  9. Persidis, A. 1997. Industry Trends: Combinatorial chemistry. Nature Biotechnology 15: 479–480.

    Article  CAS  Google Scholar 

  10. Holmes, A.B., and Stephenson, G.R. 1996. Organic chemistry. Chem. & Ind. 24: 988.

  11. Cannarsa, M.J. 1996. Single enantiomer drugs: new strategies and directions. Chem. & Ind. 10: 374-378.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. vice president for business development, Argbnex Inc., 2044 India Road, Charlottesville, VA, 22901

    Arts Persidis

Authors
  1. Arts Persidis
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persidis, A. Chiral-based therapeutics. Nat Biotechnol 15, 594–595 (1997). https://doi.org/10.1038/nbt0697-594

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0697-594

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing